SynthesisAnnals of oncology : official journal of the European Society for Medical Oncology2017

Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab.

D Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.